We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.11B
| $227K | ﹤0.01% |
+5,200
| New | +$265K |
|
3027
Ameris Bancorp
ABCB
$5.92B
| $226K | ﹤0.01% |
5,062
-19,714
| -80% | -$904K |
|
|
SASR
3028
DELISTED
Sandy Spring Bancorp Inc
SASR
| $226K | ﹤0.01% |
+6,407
| New | +$253K |
|
3029
Nerdy
NRDY
$108M
| $225K | ﹤0.01% |
106,681
-169,610
| -61% | -$455K |
|
|
ZEPP
3030
Zepp Health
ZEPP
$68.6M
| $222K | ﹤0.01% |
40,793
-14,693
| -26% | -$106K |
|
3031
CarParts.com
PRTS
$44.1M
| $221K | ﹤0.01% |
+4,273
| New | +$311K |
|
|
HOFVW
3032
CALL
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
| $218K | ﹤0.01% |
395,709
-9,291
| -2% | -$1.48K |
|
|
NVVEW
3033
CALL
DELISTED
Newborn Acquisition Corp Warrant
NVVEW
| $218K | ﹤0.01% |
155,998
-114,002
| -42% | -$31.4K |
|
3034
Remitly
RELY
$4.9B
| $218K | ﹤0.01% |
19,640
| – | – |
|
|
SKYAW
3035
CALL
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
| $218K | ﹤0.01% |
21,933
| – | – |
|
|
BCYC
3036
Bicycle Therapeutics
BCYC
$276M
| $216K | ﹤0.01% |
9,271
-70,852
| -88% | -$1.69M |
|
3037
Encompass Health
EHC
$11.6B
| $216K | ﹤0.01% |
4,800
-55,526
| -92% | -$2.78M |
|
|
SURF
3038
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $216K | ﹤0.01% |
206,953
+92,770
| +81% | +$148K |
|
|
CMRC
3039
Commerce.com Inc Series 1
CMRC
$260M
| $215K | ﹤0.01% |
14,506
-74,638
| -84% | -$1.28M |
|
|
INVX
3040
Innovex International
INVX
$1.79B
| $213K | ﹤0.01% |
+10,952
| New | +$254K |
|
3041
Helix Energy Solutions
HLX
$1.34B
| $210K | ﹤0.01% |
+54,400
| New | +$206K |
|
|
LND
3042
BrasilAgro
LND
$364M
| $210K | ﹤0.01% |
37,391
-13,413
| -26% | -$68.3K |
|
|
TEAD
3043
Teads Holding Co
TEAD
$78.6M
| $210K | ﹤0.01% |
57,694
-93,680
| -62% | -$455K |
|
3044
Park-Ohio Holdings
PKOH
$563M
| $210K | ﹤0.01% |
18,608
-8,883
| -32% | -$146K |
|
|
EPIX
3045
DELISTED
ESSA Pharma
EPIX
| $209K | ﹤0.01% |
115,122
+93,729
| +438% | +$247K |
|
3046
Canadian Pacific Kansas City
CP
$81.5B
| $208K | ﹤0.01% |
+3,100
| New | +$234K |
|
3047
Ezcorp Inc
EZPW
$1.84B
| $207K | ﹤0.01% |
+26,850
| New | +$222K |
|
3048
Gladstone Capital
GLAD
$436M
| $207K | ﹤0.01% |
12,140
-1,511
| -11% | -$30.8K |
|
|
BFX
3049
DELISTED
BowFlex Inc.
BFX
| $207K | ﹤0.01% |
126,668
-37,975
| -23% | -$76.5K |
|
3050
Deere & Co
DE
$173B
| $206K | ﹤0.01% |
617
-100
| -14% | -$34.3K |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.